General Anesthetics Inhibit Erythropoietin Induction Under Hypoxic Conditions in the Mouse Brain

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Jan 5

PMID 22216265

Citations 20

Authors

Tomoharu Tanaka

Shinichi Kai

Tomohiro Koyama

Hiroki Daijo

Takehiko Adachi

Kazuhiko Fukuda

Kiichi Hirota

Affiliations

Soon will be listed here.

Abstract

Background: Erythropoietin (EPO), originally identified as a hematopoietic growth factor produced in the kidney and fetal liver, is also endogenously expressed in the central nervous system (CNS). EPO in the CNS, mainly produced in astrocytes, is induced under hypoxic conditions in a hypoxia-inducible factor (HIF)-dependent manner and plays a dominant role in neuroprotection and neurogenesis. We investigated the effect of general anesthetics on EPO expression in the mouse brain and primary cultured astrocytes.

Methodology/principal Findings: BALB/c mice were exposed to 10% oxygen with isoflurane at various concentrations (0.10-1.0%). Expression of EPO mRNA in the brain was studied, and the effects of sevoflurane, halothane, nitrous oxide, pentobarbital, ketamine, and propofol were investigated. In addition, expression of HIF-2α protein was studied by immunoblotting. Hypoxia-induced EPO mRNA expression in the brain was significantly suppressed by isoflurane in a concentration-dependent manner. A similar effect was confirmed for all other general anesthetics. Hypoxia-inducible expression of HIF-2α protein was also significantly suppressed with isoflurane. In the experiments using primary cultured astrocytes, isoflurane, pentobarbital, and ketamine suppressed hypoxia-inducible expression of HIF-2α protein and EPO mRNA.

Conclusions/significance: Taken together, our results indicate that general anesthetics suppress activation of HIF-2 and inhibit hypoxia-induced EPO upregulation in the mouse brain through a direct effect on astrocytes.

Citing Articles

Microglial EPOR Contribute to Sevoflurane-induced Developmental Fine Motor Deficits Through Synaptic Pruning in Mice.

He D, Shi X, Liang L, Zhao Y, Ma S, Cao S Neurosci Bull. 2024; 40(12):1858-1874.

PMID: 38907076 PMC: 11625042. DOI: 10.1007/s12264-024-01248-5.

The inhibitory effects of Orengedokuto on inducible PGE2 production in BV-2 microglial cells.

Iwata Y, Miyao M, Hirotsu A, Tatsumi K, Matsuyama T, Uetsuki N Heliyon. 2021; 7(8):e07759.

PMID: 34458607 PMC: 8377439. DOI: 10.1016/j.heliyon.2021.e07759.

Hypoxia-dependent signaling in perioperative and critical care medicine.

Hirota K J Anesth. 2021; 35(5):741-756.

PMID: 34003375 PMC: 8128984. DOI: 10.1007/s00540-021-02940-w.

Basic Biology of Hypoxic Responses Mediated by the Transcription Factor HIFs and its Implication for Medicine.

Hirota K Biomedicines. 2020; 8(2).

PMID: 32069878 PMC: 7168341. DOI: 10.3390/biomedicines8020032.

Propofol inhibits stromatoxin-1-sensitive voltage-dependent K channels in pancreatic β-cells and enhances insulin secretion.

Kusunoki M, Hayashi M, Shoji T, Uba T, Tanaka H, Sumi C PeerJ. 2019; 7:e8157.

PMID: 31824770 PMC: 6894434. DOI: 10.7717/peerj.8157.

References

Ginsberg M . Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke. 2008; 40(3 Suppl):S111-4. PMC: 2697575. DOI: 10.1161/STROKEAHA.108.528877. View

Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M . Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med. 2002; 8(8):495-505. PMC: 2040012. View

Rappaport B, Mellon R, Simone A, Woodcock J . Defining safe use of anesthesia in children. N Engl J Med. 2011; 364(15):1387-90. DOI: 10.1056/NEJMp1102155. View

Hu C, Iyer S, Sataur A, Covello K, Chodosh L, Simon M . Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells. Mol Cell Biol. 2006; 26(9):3514-26. PMC: 1447431. DOI: 10.1128/MCB.26.9.3514-3526.2006. View

Gu G, Li Y, Peng Z, Xu J, Kang Z, Xu W . Mechanism of ischemic tolerance induced by hyperbaric oxygen preconditioning involves upregulation of hypoxia-inducible factor-1alpha and erythropoietin in rats. J Appl Physiol (1985). 2008; 104(4):1185-91. DOI: 10.1152/japplphysiol.00323.2007. View

Sato Y, Kobayashi E, Murayama T, Mishina M, Seo N . Effect of N-methyl-D-aspartate receptor epsilon1 subunit gene disruption of the action of general anesthetic drugs in mice. Anesthesiology. 2005; 102(3):557-61. DOI: 10.1097/00000542-200503000-00013. View

Taylor C . Mitochondria and cellular oxygen sensing in the HIF pathway. Biochem J. 2007; 409(1):19-26. DOI: 10.1042/BJ20071249. View

Holmquist-Mengelbier L, Fredlund E, Lofstedt T, Noguera R, Navarro S, Nilsson H . Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell. 2006; 10(5):413-23. DOI: 10.1016/j.ccr.2006.08.026. View

Stockmann C, Fandrey J . Hypoxia-induced erythropoietin production: a paradigm for oxygen-regulated gene expression. Clin Exp Pharmacol Physiol. 2006; 33(10):968-79. DOI: 10.1111/j.1440-1681.2006.04474.x. View

10.

Sofroniew M, Vinters H . Astrocytes: biology and pathology. Acta Neuropathol. 2009; 119(1):7-35. PMC: 2799634. DOI: 10.1007/s00401-009-0619-8. View

11.

Yamasaki M, Mishima H, Yamashita H, Kashiwagi K, Murata K, Minamoto A . Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells. Brain Res. 2005; 1050(1-2):15-26. DOI: 10.1016/j.brainres.2005.05.037. View

12.

Raphael J, Zuo Z, Abedat S, Beeri R, Gozal Y . Isoflurane preconditioning decreases myocardial infarction in rabbits via up-regulation of hypoxia inducible factor 1 that is mediated by mammalian target of rapamycin. Anesthesiology. 2008; 108(3):415-25. DOI: 10.1097/ALN.0b013e318164cab1. View

13.

Chen G, Shi J, Hang C, Xie W, Liu J, Liu X . Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO). Neurosci Lett. 2007; 425(3):177-82. DOI: 10.1016/j.neulet.2007.08.022. View

14.

Fink B, Haschke R . Anesthetic effects on cerebral metabolism. Anesthesiology. 1973; 39(2):199-215. DOI: 10.1097/00000542-197308000-00011. View

15.

Ntaios G, Savopoulos C, Chatzinikolaou A, Hatzitolios A . The neuroprotective role of erythropoietin in the management of acute ischaemic stroke: from bench to bedside. Acta Neurol Scand. 2008; 118(6):362-6. DOI: 10.1111/j.1600-0404.2008.01039.x. View

16.

Wang G, Semenza G . General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A. 1993; 90(9):4304-8. PMC: 46495. DOI: 10.1073/pnas.90.9.4304. View

17.

Weidemann A, Johnson R . Nonrenal regulation of EPO synthesis. Kidney Int. 2009; 75(7):682-8. DOI: 10.1038/ki.2008.687. View

18.

Itoh T, Namba T, Fukuda K, Semenza G, Hirota K . Reversible inhibition of hypoxia-inducible factor 1 activation by exposure of hypoxic cells to the volatile anesthetic halothane. FEBS Lett. 2001; 509(2):225-9. DOI: 10.1016/s0014-5793(01)03119-2. View

19.

Wang G, Jiang B, Rue E, Semenza G . Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A. 1995; 92(12):5510-4. PMC: 41725. DOI: 10.1073/pnas.92.12.5510. View

20.

Selim M . Perioperative stroke. N Engl J Med. 2007; 356(7):706-13. DOI: 10.1056/NEJMra062668. View